Clinical biochemistry最新文献

筛选
英文 中文
Development and preliminary validation of an LC-MS/MS method for sunitinib therapeutic drug monitoring using quantitative dried blood spots with a blood-to-plasma conversion formula. 基于血-血浆转化公式的定量干血点舒尼替尼治疗药物监测的LC-MS/MS方法的开发和初步验证
IF 2.3 3区 医学
Clinical biochemistry Pub Date : 2026-11-13 DOI: 10.1016/j.clinbiochem.2026.111222
Qiaoqiao Li, Maocai Tang, Tiantian Tang, Jin Zeng, Min Zhang, Xiaoxiao Wang, Wanyi Chen, Lixian Li
{"title":"Development and preliminary validation of an LC-MS/MS method for sunitinib therapeutic drug monitoring using quantitative dried blood spots with a blood-to-plasma conversion formula.","authors":"Qiaoqiao Li, Maocai Tang, Tiantian Tang, Jin Zeng, Min Zhang, Xiaoxiao Wang, Wanyi Chen, Lixian Li","doi":"10.1016/j.clinbiochem.2026.111222","DOIUrl":"https://doi.org/10.1016/j.clinbiochem.2026.111222","url":null,"abstract":"<p><strong>Objectives: </strong>Conventional venous sampling cannot reliably ensure accurate collection timing, potentially affecting therapeutic drug monitoring (TDM) of sunitinib (SUN). Quantitative dried blood spot (qDBS) sampling offers a patient-centric alternative; however, reliable DBS-to-plasma conversion requires validation. This study therefore aims to develop and preliminarily validate a qDBS-to-plasma conversion formula for SUN TDM.</p><p><strong>Design & methods: </strong>A qDBS based method was developed and validated for simultaneous quantification of SUN and its active metabolite N-desethyl sunitinib (SU12662). Analytical validation followed FDA and IATDMCT guidelines. The impact of hematocrit (Hct) on quantification was evaluated. Thirty-eight paired DBS and plasma samples were concentration-stratified and randomly divided into a derivation set (n = 20) and a validation set (n = 18). Passing-Bablok regression was used to establish conversion equations, which were evaluated by Bland-Altman analysis and the EMA ±20% acceptance criterion.</p><p><strong>Results: </strong>The method demonstrated satisfactory analytical performance. Hct-related bias was negligible within 30%-50%, supporting conversion without additional Hct correction. Passing-Bablok regression generated the conversion equations: C<sub>DBS</sub> = -3.61 + 1.69 × C<sub>pla</sub> for SUN and C<sub>DBS</sub> = -1.42 + 1.70 × C<sub>pla</sub> for SU12662. In the validation set, Bland-Altman analysis showed minimal bias between estimated and measured plasma concentrations (SUN: -0.91%; SU12662: 4.58%). The EMA ±20% criterion was met for 14/18 SUN samples (77.8%) and 18/18 SU12662 samples (100%).</p><p><strong>Conclusions: </strong>This study developed and preliminarily validated a qDBS-based conversion strategy for SUN TDM. The minimal Hct effect and acceptable agreement in the validation set support further evaluation of qDBS for patient-centric SUN TDM.</p>","PeriodicalId":10172,"journal":{"name":"Clinical biochemistry","volume":"146 ","pages":"111222"},"PeriodicalIF":2.3,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation of a large automated Analyzer system in clinical biochemistry laboratories: A practical framework. 临床生物化学实验室大型自动化分析系统的实施:一个实用的框架。
IF 2.3 3区 医学
Clinical biochemistry Pub Date : 2026-10-07 DOI: 10.1016/j.clinbiochem.2026.111212
Felix Leung
{"title":"Implementation of a large automated Analyzer system in clinical biochemistry laboratories: A practical framework.","authors":"Felix Leung","doi":"10.1016/j.clinbiochem.2026.111212","DOIUrl":"10.1016/j.clinbiochem.2026.111212","url":null,"abstract":"<p><p>Automation has become essential in clinical biochemistry laboratories to meet increasing demands for efficiency, standardization, and reliable turnaround times. Large automated analyzer (LAA) systems are now central to modern laboratory operations and are frequently integrated within total laboratory automation solutions encompassing pre-analytical, analytical, and post-analytical workflows. However, the implementation of LAA systems is complex and requires coordinated oversight across scientific, operational, informatics, and vendor stakeholders. This article presents a practical framework for the validation and implementation of LAA systems from the perspective of a clinical biochemist. Key aspects discussed include pre-implementation planning, management of unanticipated challenges, and implementation strategy with real world examples from our institutional experience. The overall goal of this article is to demonstrate that approaching LAA implementations with structured planning, effective collaboration, and risk-based decision-making can ensure implementation success in terms of analytical quality, operational continuity, and patient safety.</p>","PeriodicalId":10172,"journal":{"name":"Clinical biochemistry","volume":" ","pages":"111212"},"PeriodicalIF":2.3,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149126793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
WITHDRAWN: Multiple myeloma revealed by a pulmonary embolism, with more anodal migration of λ IgG in the β2 region on serum protein electrophoresis. 肺栓塞显示多发性骨髓瘤,血清蛋白电泳显示λ IgG在β2区有更多的阳极迁移。
IF 2.3 3区 医学
Clinical biochemistry Pub Date : 2026-04-29 DOI: 10.1016/j.clinbiochem.2026.111128
Chaymae Benmoussa, Ayoub Baroudi, Oumayma Abdesselami, Kaoutar Ghomari, Dounia El Moujtahide, El Houcine Sebbar, Mohammed Choukri
{"title":"WITHDRAWN: Multiple myeloma revealed by a pulmonary embolism, with more anodal migration of λ IgG in the β<sub>2</sub> region on serum protein electrophoresis.","authors":"Chaymae Benmoussa, Ayoub Baroudi, Oumayma Abdesselami, Kaoutar Ghomari, Dounia El Moujtahide, El Houcine Sebbar, Mohammed Choukri","doi":"10.1016/j.clinbiochem.2026.111128","DOIUrl":"10.1016/j.clinbiochem.2026.111128","url":null,"abstract":"<p><strong>Introduction: </strong>Serum protein electrophoresis (SPE) is widely used to detect monoclonal gammopathies and other hematologic or inflammatory disorders. IgG monoclonal proteins typically migrate in the gamma region, while IgA frequently migrates in the beta region. However, IgG migration in the β<sub>2</sub> region is an exceptionally rare occurrence that can pose significant diagnostic challenges.</p><p><strong>Case presentation: </strong>We present the case of a 76-year-old woman who was initially diagnosed with acute bilateral pulmonary embolism and deep vein thrombosis as the first clinical manifestation of multiple myeloma. Laboratory findings revealed hypercalcemia, mild anemia, and a monoclonal IgG lambda peak in the β<sub>2</sub> region, which was confirmed by immunofixation. Echocardiography revealed left ventricular dilation with preserved right-sided heart structures. Ten days later, the patient developed cauda equina syndrome due to spinal involvement, requiring urgent surgical decompression.</p><p><strong>Discussion: </strong>This case highlights three exceptionally rare and clinically significant features: (1) IgG monoclonal protein migration in the β<sub>2</sub> region, (2) pulmonary embolism as the first manifestation of multiple myeloma, and (3) severe skeletal complications after minimal trauma. Clinicians should consider underlying monoclonal gammopathy in unexplained thromboembolic events and exercise caution when interpreting atypical SPE patterns, which may be crucial for early diagnosis. The unusual combination of these findings underscores the importance of a comprehensive approach to diagnosing plasma cell disorders.</p><p><strong>Conclusion: </strong>Recognition of more anodal IgG migration and awareness of thromboembolic presentation are crucial to ensure early diagnosis and appropriate management of multiple myeloma.</p>","PeriodicalId":10172,"journal":{"name":"Clinical biochemistry","volume":" ","pages":"111128"},"PeriodicalIF":2.3,"publicationDate":"2026-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147811658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autoantibody testing in neuromuscular medicine: assay technologies, interpretation, and clinical utility 神经肌肉医学中的自身抗体检测:分析技术、解释和临床应用。
IF 2.1 3区 医学
Clinical biochemistry Pub Date : 2026-03-01 Epub Date: 2026-02-01 DOI: 10.1016/j.clinbiochem.2026.111092
Tony Zhang , John R. Mills , Divyanshu Dubey , Christopher J. Klein
{"title":"Autoantibody testing in neuromuscular medicine: assay technologies, interpretation, and clinical utility","authors":"Tony Zhang ,&nbsp;John R. Mills ,&nbsp;Divyanshu Dubey ,&nbsp;Christopher J. Klein","doi":"10.1016/j.clinbiochem.2026.111092","DOIUrl":"10.1016/j.clinbiochem.2026.111092","url":null,"abstract":"<div><div>Neuromuscular autoantibody testing is an essential component in the diagnosis and management of autoimmune neuromuscular disorders. These immune-mediated diseases target antigens found in nerves, muscles, and neuromuscular junctions, and may occasionally involve the central nervous system, resulting in complex clinical presentations. Developments in antibody identification and validation have provided clinically relevant biomarkers for diagnostic, therapeutic, and prognostic purposes. Among antibody-associated neuromuscular disorders, paraneoplastic onconeural autoantibodies are of particular significance, as their presence may direct search for specific underlying malignancies. Appropriate ordering and interpretation of these tests should be integrated with clinical and electrodiagnostic (CEDX) findings. Given that these disorders are often rare, estimating an optimal pre-test probability is important to improve test accuracy and reduce false positive outcomes. Online clinical calculators are available to help clinicians determine appropriate testing strategies for some disorders. This review summarizes principal neuromuscular antibodies, current testing approaches, and the influence of laboratory data on patient care.</div></div>","PeriodicalId":10172,"journal":{"name":"Clinical biochemistry","volume":"142 ","pages":"Article 111092"},"PeriodicalIF":2.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146112400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evidence-based extension of reagent shelf-life beyond expiry using patient-based moving averages, westgard sigma rules, and CLSI EP25 使用基于患者的移动平均线、westgard sigma规则和CLSI EP25,循证延长试剂的保质期。
IF 2.1 3区 医学
Clinical biochemistry Pub Date : 2026-03-01 Epub Date: 2026-02-01 DOI: 10.1016/j.clinbiochem.2026.111094
Mohamed Mokhtar Khelil , Tony Badrick
{"title":"Evidence-based extension of reagent shelf-life beyond expiry using patient-based moving averages, westgard sigma rules, and CLSI EP25","authors":"Mohamed Mokhtar Khelil ,&nbsp;Tony Badrick","doi":"10.1016/j.clinbiochem.2026.111094","DOIUrl":"10.1016/j.clinbiochem.2026.111094","url":null,"abstract":"<div><h3>Background</h3><div>Reagent stability is a significant determinant of analytical reliability in clinical laboratories. Post-expiry reagent use is often discouraged due to the potential risk of systematic bias; however, empirical data supporting or refuting such restrictions are limited.</div></div><div><h3>Methods</h3><div>This study evaluated the post-expiry performance of free T3 (FT3) and free T4 (FT4) immunoassays on the Abbott Architect i1000SR analyzer using an integrated framework combining three complementary approaches: (i) a simulation-optimized moving average (MA) model based on real patient data (ii) Westgard Sigma rules quality control, and (iii) Clinical and Laboratory Standards Institute EP25-A drift analysis. The MA was optimised via Monte Carlo simulations using a step-shift bias model, which defined the optimal window size (N) for 90% detection power and 0% false rejection rate. Stability was then assessed across three reagent lots per analyte, spanning both pre- and post-expiration phases.</div></div><div><h3>Results</h3><div>Westgard rules provided the earliest analytical alerts, while EP25 confirmed sustained drift relative to allowable total error. The MA detected progressive instability, showing strong concordance with EP25 after lag correction (N × cadence). FT4 indicated extended stability of up to 19 months post-expiry, while FT3 showed limited stability (&lt;4 months). These differences reflected distinct assay robustness and kinetics.</div></div><div><h3>Conclusions</h3><div>The combination of Westgard sigma rules, EP25, and simulation-optimized MA provides a reproducible, data-driven framework for post-expiry reagent stability assessment. Optimizing MA with real patient data enhances detection performance, bridging theoretical quality-control design and routine laboratory application. This integrated approach enables laboratories to make scientifically justified, cost-effective decisions regarding reagent reuse beyond manufacturer expiry dates.</div></div>","PeriodicalId":10172,"journal":{"name":"Clinical biochemistry","volume":"142 ","pages":"Article 111094"},"PeriodicalIF":2.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146112382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Improving the environmental impact paradox of clinical medical laboratories” [Clin. Biochem. 141 (2026) 111063] “改善临床医学实验室的环境影响悖论”的勘误表[临床。生物化学学报,2014,29(3):444 - 444。
IF 2.1 3区 医学
Clinical biochemistry Pub Date : 2026-03-01 Epub Date: 2026-02-12 DOI: 10.1016/j.clinbiochem.2026.111091
Pernilla Sörme, Scott Weitze
{"title":"Corrigendum to “Improving the environmental impact paradox of clinical medical laboratories” [Clin. Biochem. 141 (2026) 111063]","authors":"Pernilla Sörme,&nbsp;Scott Weitze","doi":"10.1016/j.clinbiochem.2026.111091","DOIUrl":"10.1016/j.clinbiochem.2026.111091","url":null,"abstract":"","PeriodicalId":10172,"journal":{"name":"Clinical biochemistry","volume":"142 ","pages":"Article 111091"},"PeriodicalIF":2.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interference and failure: The challenge of high-concentration IgM monoclonal protein in capillary zone electrophoresis 干扰与失败:高浓度IgM单克隆蛋白在毛细管区带电泳中的挑战。
IF 2.1 3区 医学
Clinical biochemistry Pub Date : 2026-03-01 Epub Date: 2026-02-15 DOI: 10.1016/j.clinbiochem.2026.111099
Yanhua Zhao, Minjie Zhang, Wei Gan
{"title":"Interference and failure: The challenge of high-concentration IgM monoclonal protein in capillary zone electrophoresis","authors":"Yanhua Zhao,&nbsp;Minjie Zhang,&nbsp;Wei Gan","doi":"10.1016/j.clinbiochem.2026.111099","DOIUrl":"10.1016/j.clinbiochem.2026.111099","url":null,"abstract":"<div><h3>Background</h3><div>Capillary zone electrophoresis (CZE) is a standard method for serum protein separation, but its performance can be compromised by IgM monoclonal proteins, leading to false-negative results.</div></div><div><h3>Methods</h3><div>We report a case of Waldenström macroglobulinemia (IgM 56.05 g/L) with repeated CZE failure. Immunofixation electrophoresis (IFE) confirmed an IgM kappa monoclonal protein. Four pretreatment protocols were evaluated: 1) 37°C incubation; 2) dilution with distilled water; 3) dilution with 0.9% saline; and 4) pretreatment with β‑mercaptoethanol (BME). Gel-based serum protein electrophoresis (SPE) and immunosubtraction CZE were also performed to investigate the interference mechanism.</div></div><div><h3>Results</h3><div>Initial CZE failed to yield an interpretable electrophoretogram. Incubation at 37°C showed no improvement. Dilution with distilled water induced visible precipitation and resulted in a false-negative electrophoretic pattern with a marked drop in measured total protein. Dilution with saline prevented precipitation but still failed to reveal a distinct monoclonal spike, despite biochemical measurements consistent with high globulin levels. In contrast, pretreatment with BME successfully restored a clear monoclonal spike in the β‑γ region on CZE, demonstrating restored solubility and proper migration. IFE corroborated the presence of the IgM kappa monoclonal protein. Gel-based SPE successfully showed a distinct M-protein band without interference, while immunosubtraction CZE failed under both temperature conditions, supporting cryoglobulin-related interference.</div></div><div><h3>Conclusions</h3><div>Very high IgM concentrations, particularly with cryoglobulin activity, can cause complete CZE failure not resolved by standard dilution or heating. The interference likely involves capillary obstruction from protein aggregation or temperature-dependent re-precipitation within the capillary. BME pretreatment is a critical intervention for unmasking IgM monoclonal proteins when CZE results are inconsistent with other laboratory findings, thereby preventing diagnostic errors.</div></div>","PeriodicalId":10172,"journal":{"name":"Clinical biochemistry","volume":"142 ","pages":"Article 111099"},"PeriodicalIF":2.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146212277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing precision, bias, and sigma metrics of 22 measurands using Ricos and EFLM specifications and implementation of internal quality control procedure in clinical chemistry laboratory 使用Ricos和EFLM规范评估22种测量方法的精度、偏差和西格玛指标,并在临床化学实验室实施内部质量控制程序。
IF 2.1 3区 医学
Clinical biochemistry Pub Date : 2026-03-01 Epub Date: 2026-02-28 DOI: 10.1016/j.clinbiochem.2026.111108
Khouloud Hkimi , Sonia Gara
{"title":"Assessing precision, bias, and sigma metrics of 22 measurands using Ricos and EFLM specifications and implementation of internal quality control procedure in clinical chemistry laboratory","authors":"Khouloud Hkimi ,&nbsp;Sonia Gara","doi":"10.1016/j.clinbiochem.2026.111108","DOIUrl":"10.1016/j.clinbiochem.2026.111108","url":null,"abstract":"<div><h3>Background</h3><div>The European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) biological variation (BV) database is currently the reference source for BV-based specifications, providing evidence-based and more stringent limits than the historical Ricos database.</div></div><div><h3>Objective</h3><div>This study aimed to assess the impact of the transition from old to updated BV goals on sigma metrics in our laboratory.</div></div><div><h3>Methods</h3><div>The study was conducted at the National Institute of Salah Azaiz medical biology laboratory over an 8-month period. It included 22 biological parameters for which coefficients of variation and biases were calculated using internal and external quality control materials. Sigma metrics were determined using Ricos and the EFLM desirable specifications.</div></div><div><h3>Results</h3><div>Using Ricos desirable specifications, 27.3% of analytes (ALT, CK, iron, total bilirubin, triglycerides, and CA19-9) achieved sigma ≥ 6, 36.4% had sigma between 3 and 6 (AST, LDH, urea, uric acid, AFP, CEA, CA125, and CA15-3), and 36.4% had sigma &lt; 3 (calcium, creatinine, glucose, magnesium, potassium, sodium, total cholesterol, total protein). With the stricter EFLM targets, 6 sigma performers decreased to 19.1% (CK, iron, total bilirubin, triglycerides). 28.5% of analytes had sigma between 3 and 6 (ALT, AST, urea, uric acid, CEA, CA19-9), and 52.4% had sigma &lt; 3 (calcium, creatinine, glucose, LDH, magnesium, potassium, sodium, total cholesterol, total protein, AFP and CA125). The resulting internal quality control strategy hence differed. The quality goal index indicated that imprecision was the main limitation for most analytes.</div></div><div><h3>Conclusions</h3><div>Updating performance specifications from the historical Ricos database to the evidence-based EFLM resulted in more stringent BV goals that are challenging to achieve with current routine technologies. Intensified root-cause analysis, closer collaboration with manufacturers, and ongoing performance reassessment are necessary for poor performers.</div></div>","PeriodicalId":10172,"journal":{"name":"Clinical biochemistry","volume":"142 ","pages":"Article 111108"},"PeriodicalIF":2.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147343409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel fibrinogen mutations in pediatric patients: implications for neonatal coagulation screening and family genetic counseling 新型纤维蛋白原突变在儿科患者:新生儿凝血筛查和家庭遗传咨询的意义。
IF 2.1 3区 医学
Clinical biochemistry Pub Date : 2026-03-01 Epub Date: 2026-02-16 DOI: 10.1016/j.clinbiochem.2026.111102
Jie Jiang
{"title":"Novel fibrinogen mutations in pediatric patients: implications for neonatal coagulation screening and family genetic counseling","authors":"Jie Jiang","doi":"10.1016/j.clinbiochem.2026.111102","DOIUrl":"10.1016/j.clinbiochem.2026.111102","url":null,"abstract":"","PeriodicalId":10172,"journal":{"name":"Clinical biochemistry","volume":"142 ","pages":"Article 111102"},"PeriodicalIF":2.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146218862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outlook on ACADSB variants shaping metabolomic patterns and clinical outcomes − experience from a Central European country 对影响代谢组学模式和临床结果的ACADSB变异的展望——来自中欧国家的经验
IF 2.1 3区 医学
Clinical biochemistry Pub Date : 2026-03-01 Epub Date: 2026-02-19 DOI: 10.1016/j.clinbiochem.2026.111105
Andrej Bandura , Ján Chandoga , Jerguš Vengríni , Miriama Juhosová , Alžbeta Vavrová , Elena Gregová , Miroslava Lysinová , Zuzana Mydlová , Katarína Brennerová , Jana Šaligová , Danka Maceková , Daniel Böhmer
{"title":"Outlook on ACADSB variants shaping metabolomic patterns and clinical outcomes − experience from a Central European country","authors":"Andrej Bandura ,&nbsp;Ján Chandoga ,&nbsp;Jerguš Vengríni ,&nbsp;Miriama Juhosová ,&nbsp;Alžbeta Vavrová ,&nbsp;Elena Gregová ,&nbsp;Miroslava Lysinová ,&nbsp;Zuzana Mydlová ,&nbsp;Katarína Brennerová ,&nbsp;Jana Šaligová ,&nbsp;Danka Maceková ,&nbsp;Daniel Böhmer","doi":"10.1016/j.clinbiochem.2026.111105","DOIUrl":"10.1016/j.clinbiochem.2026.111105","url":null,"abstract":"<div><h3>Background</h3><div>Short/branched-chain acyl-CoA dehydrogenase deficiency (SBCADD) is an autosomal recessive defect of L-isoleucine catabolism caused by pathogenic variants in the <em>ACADSB</em> gene. While early reports described neurological symptoms, expanded newborn screening cohorts have revealed predominantly asymptomatic individuals, raising questions regarding the clinical significance and optimal management.</div></div><div><h3>Methods</h3><div>We performed an evaluation of three probands with a biochemical profile consistent with SBCADD identified in a Central European country. Acylcarnitines were measured by liquid chromatography with tandem mass spectrometry, urinary organic acids by gas chromatography with mass spectrometry, and <em>ACADSB</em> was sequenced. Clinical data were collected from regional paediatric follow-up.</div></div><div><h3>Results</h3><div>Three individuals with a biochemical profile consistent with SBCADD were identified in Slovakia. Two were detected through newborn screening, whereas one was diagnosed at 5 years of age. All three showed elevated C5-acylcarnitine; the C5/C8 ratio was increased in two patients, while in the third it remained within the reference range despite persistently elevated C5. Urinary 2-methylbutyrylglycine and 2-ethyl-3-hydroxypropionate were elevated in all cases and showed intra-individual variability; in one sample, 2-methylbutyrylglycine remained increased while 2-ethyl-3-hydroxypropionate had normalised. Two patients carried pathogenic <em>ACADSB</em> variants (one homozygous splice-site variant c.303 + 1G &gt; A, one compound heterozygous for p.Thr148Ile and p.Glu387Lys), whereas genetic testing was not performed in the third case. Over the available follow-up period, no episodes of metabolic decompensation were observed; two patients remained clinically well, and one patient had autism spectrum disorder. Free carnitine concentrations were within the reference range in all probands.</div></div><div><h3>Conclusions</h3><div>Our findings support SBCADD as a primarily biochemical phenotype with a largely benign course, while illustrating variability of urinary biomarkers and C5/C8 ratios. Accurate differentiation from isovaleric acidemia and careful integration of biochemical, genetic and clinical data remain essential.</div></div>","PeriodicalId":10172,"journal":{"name":"Clinical biochemistry","volume":"142 ","pages":"Article 111105"},"PeriodicalIF":2.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146776021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书